Skip to main content
. 2014 May 23;9(5):e98364. doi: 10.1371/journal.pone.0098364

Figure 8. The effect of NAT treatment on albumin immunoreactivity following SCI.

Figure 8

Albumin immunoreactivity at 10(A), within the injury epicentre (B) and at 10 mm caudal (C). Sham sections (D) demonstrated minimal immunoreactivity. Immunoreactivity was significantly increased at both 5 and 24 hours post-SCI. Representative images at 24 hours are shown within the injury epicentre (E-vehicle, F-NAT) and adjacent segment (G-vehicle, H-NAT). By 3 days post-SCI albumin immunoreactivity began to reduce within the injury epicentre (I-vehicle, J-NAT) and adjacent segment (K-vehicle, L-NAT), though NAT treatment resulted in significantly greater albumin immunoreactivity when compared to vehicle. Albumin immunoreactivity reduced further by 2 weeks post-SCI within the injury epicentre (M-vehicle, N-NAT), returning to sham levels within the adjacent segments (O-vehicle, P-NAT). *denotes p<0.05, **denotes p<0.01, ***denotes p<0.001 when compared to sham. Mean sham values indicated by the dashed line. Scale bar  = 1 mm.